Active Pharmaceutical Ingredients Market by Manufacturing Type and Geography — Forecast and Analysis 2020–2024

During 2020–2024 active pharmaceutical ingredients market size will grow by $ 60.56 billion over at a CAGR of almost 6%.

Asia will provide significant growth opportunities to vendors. During the forecast period the region will account for 66% of the market’s growth.

Market Overview

Get sample illustrations from Technavio’s research report on the active pharmaceutical ingredients market

Growth in the market will be driven by factors such as the increasing number of type II DMFs. The paradigm shift in API manufacturing will also have a significant influence on the growth of the active pharmaceutical ingredients market during the forecast period.

Though the market will offer several growth opportunities, factors such as will also challenge the growth of the market participants.

Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., Jazz Pharmaceuticals Plc, and Lupin Ltd. are some of the key active pharmaceutical ingredients market vendors.

The report provides an analysis of the market’s competitive landscape, the strategies adopted by companies to increase their market share, and the key products or services they provide. The report also analyzes the market based on segmentations such as Type (captive API and contract API) and Geographic Landscape (Asia, Europe, North America, and ROW). To improve their market positions, the vendors should focus more on the fast-growing segments.

View our report page for more insights on the emerging market trends that will influence the growth of the active pharmaceutical ingredients market.